212 related articles for article (PubMed ID: 14619610)
1. [Effect of diet therapy on status of hemocoagulation and fibrinolysis in type 2 diabetes patients].
Alekseeva RI; Meshcheriakova VA; Sharafetdinov KhKh; Plotnikova OA; Liutova LV; Karabasova MA; Andreenko GV
Vopr Pitan; 2003; 72(5):18-21. PubMed ID: 14619610
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
3. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
4. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
5. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
[TBL] [Abstract][Full Text] [Related]
6. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
Tentolouris N; Boutati E; Karambakalis N; Perrea D; Tselepis AD; Tsoukala C; Kyriaki D; Lourida E; Anastasopoulou I; Karafoullidou A; Raptis SA; Katsilambros N
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):6-12. PubMed ID: 15871845
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the coagulation and fibrinolysis system in 54 patients with type 2 diabetes mellitus: correlations with lipid metabolism and blood glucose control].
Moccia F; Colla G; Castelli F; Greco GM
Clin Ter; 1996; 147(1-2):37-46. PubMed ID: 8767954
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
[TBL] [Abstract][Full Text] [Related]
9. [Effect of a monounsaturated fatty acids-enriched diet on the clinical and metabolic parameters in type 2 diabetic patients].
Sharafetdinov KhKh; Plotnikova OA; Kulakova SN; Alekseeva RI; Meshcheriakova VA; Mal'tsev GIu
Vopr Pitan; 2003; 72(4):20-4. PubMed ID: 12968299
[TBL] [Abstract][Full Text] [Related]
10. [Some parameters of hemostasis in diabetic patients].
Sroczyński J; Krupa G; Chełmecka E; Galwas B; Matyszczyk B
Pol Tyg Lek; 1989 May 1-8; 44(18-19):420-2. PubMed ID: 2700093
[TBL] [Abstract][Full Text] [Related]
11. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
Wakabayashi I; Masuda H
Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
[TBL] [Abstract][Full Text] [Related]
12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
Udvardy M; Pósán E
Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
Sahli D; Eriksson JW; Boman K; Svensson MK
Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
17. [Food dietary supplement efficacy in complex therapy of patients with type 2 diabetes with obesity].
Khrushcheva IuV; Mal'tsev GIu; Popova IuP; Vasil'ev AV
Vopr Pitan; 2002; 71(2):27-31. PubMed ID: 12125471
[TBL] [Abstract][Full Text] [Related]
18. [Influence of hypocaloric diet with supplemented biologically active substances with antioxidant activity on clinicometabolic parameters in type 2 diabetes mellitus patients].
Sharafetdinov KhKh; Plotnikova OA; Zykina VV; Alekseeva RI; Mal'tsev GIu; Kaganov BS
Vopr Pitan; 2009; 78(2):57-62. PubMed ID: 19514345
[TBL] [Abstract][Full Text] [Related]
19. [Effect of dietotherapy with enteral formulas on the dynamic of clinical and metabolic parameters in type 2 diabetic patients].
Sharafetdinov KhKh; Plotnikova OA; Meshcheriakova VA
Vopr Pitan; 2005; 74(2):26-32. PubMed ID: 15921201
[TBL] [Abstract][Full Text] [Related]
20. [Influence of caloric restriction diet on clinical and biochemical parameters in patients with type 2 diabetes mellitus].
Skripchenko ND; Sharafetdinov KhKh; Plotnikova OA; Meshcheriakova VA
Vopr Pitan; 2002; 71(4):13-7. PubMed ID: 12462948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
